This inventor holds 1 USPTO granted patent. Top assignee: Advanced Oxygen Technologies, Inc.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995
Title: N Ross Buckenham: Innovator in Fungal Infection Treatment
Introduction
N Ross Buckenham is a notable inventor based in Alameda, CA. He has made significant contributions to the field of medical treatments, particularly in addressing fungal infections. His innovative approach has led to the development of a unique patent that offers a new solution for treating fungal nail infections.
Latest Patents
Buckenham holds a patent for the treatment of fungal infections. This patent focuses on a method that deprives aerobic fungi of oxygen by forming an oxygen barrier over the exposed surface of an infected nail. The oxygen barriers are created by applying a liquid film-forming carrier that includes an oxygen-scavenging substance. This substance can be a transition metal chelate or complex of salicylic acid, an oxidizable organic acid or alcohol combined with a catalyzing agent, or a polycarboxylic acid chelate or complex of a transition metal or transition metal salt. This innovative method provides a promising avenue for effectively treating fungal nail infections.
Career Highlights
Buckenham is associated with Advanced Oxygen Technologies, Inc., where he continues to develop and refine his innovative treatments. His work has garnered attention for its potential to improve patient outcomes in the treatment of fungal infections.
Collaborations
Throughout his career, Buckenham has collaborated with notable colleagues, including Donald G Rosellini and Medwin M Mintzis. These collaborations have contributed to the advancement of his research and the development of effective treatment methods.
Conclusion
N Ross Buckenham's contributions to the treatment of fungal infections highlight his innovative spirit and dedication to improving healthcare solutions. His patent represents a significant advancement in the field, showcasing the potential for new treatments that can enhance patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile